Mehdi Benamar, PhD

[FCYI @FCYImmuno]

💡Our webinars are back!
Don’t miss our session on macrophage metabolism this September 18th at 1:00 PM CET.

Stoyan Ivanov (Research Director; C3M, Nice) and Malvina Seradj (Postdoc; Institute of Cancer Research, London).

🔗 Register here: https://t.co/nsTjQtFpNf

[FCYI @FCYImmuno]

Do not forget to participate! ⬇️

[FCYI @FCYImmuno]

Join us for a webinar on intestinal immunology!

Feb 6, 2025 at 5 p.m.

@JulienMamb14132 : Role of type III interferons in intestinal tissue recovery

Valentin Thevin: Identification of an intestinal TH17 cell-derived subset in cancer initiation

🔗https://t.co/MhxP2L1gpA

[FCYI @FCYImmuno]

Join us this Thursday, 21st Nov at 5 PM CET for a webinar with recent INSERM/CNRS concours laureates and comission members!
Speakers: Romain Roncagali, Soizic Garaud & Richard Danger.
They’ll share their experience & answer your questions live!

Register: https://t.co/YCkQlLNkNS

[FCYI @FCYImmuno]

Are you interested in Host pathogens? Do not miss our next webinar which will take place on October 22nd. We will have special guests: @ONeyrolles From IPBS, @JoPellegrini from CIML , and @joan_fine_ from CIIL.

📢Registration link: https://t.co/EprWE9IJBE

[FCYI @FCYImmuno]

Are you interested in Clinical Immunology? Join us on the 25th of June at 5PM CET for our next webinar with Dr. Laurent Mesnard (Sorbonne University) and @FusaroMathieu (Toulouse).

📢Registration link: https://t.co/IPUz4C5v6o

[FCYI @FCYImmuno]

It's time to register for our next webinar on Immune Tolerance 🔜 https://t.co/wWRjJbnlkq
Great line-up of speaker: Louis-Marie Charbonnier @BostonChildrens, @afreuchet1 &Morgane Hilaire @CIML_Immunology
@sfiimmunologie @y_efis

[Peter Georgiev @_petergeorgiev_]

Check out our collaborative Treg review now in print @jacionline. @MehdiBenamar18 @jameshan_sj @HaigisLab

Regulatory T cells in dominant immunologic tolerance - Journal of Allergy and Clinical Immunology https://t.co/It0mZHJ4UJ

[Manuel D Diaz-Munoz @DiazMunoz_Lab]

If you fancy Immunology, RNA Biology and sunny South of France (beach, mountains and wine) we are now recruiting @DiazMunoz_Lab @InfinityTLS (1 PhD student, 1 PostDoc).
Share with your colleagues & friends, get in contact if interested and send your CV before July.

[FCYI @FCYImmuno]

🔈Join us for a special @FCYImmuno webinar on “Next-generation CAR therapeutics”
Brillant researchers will share their expertise on CAR T cells: @j_eyquem @UCSFMedicine and @gabriel_brisou @paoli_calmettes @crcm_marseille
👉 https://t.co/CK2H5QPwKj
@y_efis @YI_dgfi @iuis_online

[Journal of Clinical Investigation @jclinicalinvest]

Notch1/CD22 signaling disrupts Tregs in multisystem inflammatory syndrome in children: https://t.co/ArO9IVoeGi
@BostonChildrens
#COVID_19 #Immunology

[Journal of Clinical Investigation @jclinicalinvest]

Notch1 signaling impairs regulatory T cells during multisystem inflammatory syndrome in children: https://t.co/yVEO03ASCG
@magalinoval & @ArditiMd @CedarsSinai highlight the NOTCH1/CD22 pathway during MIS-C & suggest relevancy in other hyperinflammatory syndromes; #Commentary

[Myriam Nabhan @MyriamNabhan]

It’s tomorrow! Join for the last webinar of the year to hear about #neutrophils, #Tregs and #aggregates from our young immunologists 😍

[Science Immunology @SciImmunology]

Behavior of regulatory T (Treg) cells can be affected by the relationship between serine/threonine kinase 4 (Stk4) and transcription factor Foxp3. @harvardmed @BostonChildrens

https://t.co/NuoDnfZv8m

[Madi Y Cissé @MadiYCiss1]

NBA Finals game 3, let's go!! @MehdiBenamar18

[Research Square Covid-19 Preprints @RS_COVID19]

Notch1-CD22-Dependent Immune Dysregulation in the SARS-CoV2-Associated Multisystem Inflammatory Syndrome in Children #covid https://t.co/DWJ4hJginh